The mechanism of action of the compounds was probed by fluorescence and competition studies in T98G glioma cell lines, which indicated for compounds 1 and 4 a direct interaction between the inhibitor and the active site of the APE1 protein. The gene discussed is APEX1; the disease is glioma.